The DOI matches its Crossref record; 409 of the 409 references it cites were found in a registry or an index.
Raf Family Kinases: Old Dogs Have Learned New Tricks
Open accessAbstract
First identified in the early 1980s as retroviral oncogenes, the Raf proteins have been the objects of intense research. The discoveries 10 years later that the Raf family members (Raf-1, B-Raf, and A-Raf) are bona fide Ras effectors and upstream activators of the ubiquitous ERK pathway increased the interest in these proteins primarily because of the central role that this cascade plays in cancer development. The important role of Raf in cancer was corroborated in 2002 with the discovery of B-Raf genetic mutations in a large number of tumors. This led to intensified drug development efforts to target Raf signaling in cancer. This work yielded not only recent clinical successes but also surprising insights into the regulation of Raf proteins by homodimerization and heterodimerization. Surprising insights also came from the hunt for new Raf targets. Although MEK remains the only widely accepted Raf substrate, new kinase-independent roles for Raf proteins have emerged. These include the regulation of apoptosis by suppressing the activity of the proapoptotic kinases, ASK1 and MST2, and the regulation of cell motility and differentiation by controlling the activity of Rok-α. In this review, we discuss the regulation of Raf proteins and their role in cancer, with special focus on the interacting proteins that modulate Raf signaling. We also describe the new pathways controlled by Raf proteins and summarize the successes and failures in the development of efficient anticancer therapies targeting Raf. Finally, we also argue for the necessity of more systemic approaches to obtain a better understanding of how the Ras-Raf signaling network generates biological specificity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
Wilhelm, S. M., Carter, C., Tang, L., Wilkie, D., McNabola, A., Rong, H., Chen, C., Zhang, X., Vincent, P., McHugh, M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1443 · Cited by 4,017
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Flaherty, K. T., Puzanov, I., Kim, K. B., Ribas, A., McArthur, G. A., Sosman, J. A., O'Dwyer, P. J., Lee, R. J., Grippo, J. F., Nolop, K., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002011 · Cited by 3,103
MAP kinase signalling pathways in cancer
Dhillon, A. S., Hagan, S., Rath, O., & Kolch, W. (2007) · Oncogene · doi:10.1038/sj.onc.1210421 · Cited by 2,995
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820
Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF
Wan, P. T. C., Garnett, M. J., Roe, S. M., Lee, S., Niculescu-Duvaz, D., Good, V. M., Project, C. G., Jones, C. M., Marshall, C. J., Springer, C. J., et al. (2004) · Cell · doi:10.1016/s0092-8674(04)00215-6 · Cited by 2,808
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
Roberts, P. J., & Der, C. J. (2007) · Oncogene · doi:10.1038/sj.onc.1210422 · Cited by 2,788
The Hippo Signaling Pathway in Development and Cancer
Pan, D. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.09.011 · Cited by 2,269
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Mendel, D. B., Laird, A., Xin, X., Louie, S. G., Christensen, J. G., Li, G., Schreck, R., Abrams, T. J., Ngai, T. J., Lee, L. B., et al. (2003) · PubMed · Cited by 1,961
Phosphatidylinositol-3-OH kinase direct target of Ras
Rodriguez-Viciana, P., Warne, P. H., Dhand, R., Vanhaesebroeck, B., Gout, I., Fry, M. J., Waterfield, M. D., & Downward, J. (1994) · Nature · doi:10.1038/370527a0 · Cited by 1,954
Mammalian Ras interacts directly with the serine/threonine kinase raf
Vojtek, A. B., Hollenberg, S. M., & Cooper, J. A. (1993) · Cell · doi:10.1016/0092-8674(93)90307-c · Cited by 1,941
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
Poulikakos, P. I., Zhang, C., Bollag, G., Shokat, K. M., & Rosen, N. (2010) · Nature · doi:10.1038/nature08902 · Cited by 1,811
High frequency of BRAF mutations in nevi
Pollock, P. M., Harper, U. L., Hansen, K. S., Yudt, L. M., Stark, M., Robbins, C. M., Moses, T. Y., Hostetter, G., Wagner, U., Kakareka, J., et al. (2003) · Nature Genetics · doi:10.1038/ng1054 · Cited by 1,730
RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth
Hatzivassiliou, G., Song, K., Yen, I., Brandhuber, B. J., Anderson, D. J., Alvarado, R., Ludlam, M. J. C., Stokoe, D., Gloor, S. L., Vigers, G., et al. (2010) · Nature · doi:10.1038/nature08833 · Cited by 1,622
The Structural Basis for 14-3-3:Phosphopeptide Binding Specificity
Yaffe, M. B., Rittinger, K., Volinia, S., Caron, P. R., Aitken, A., Leffers, H., Gamblin, S. J., Smerdon, S. J., & Cantley, L. C. (1997) · Cell · doi:10.1016/s0092-8674(00)80487-0 · Cited by 1,604
Hyperactive Ras in developmental disorders and cancer
Schubbert, S., Shannon, K., & Bollag, G. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2109 · Cited by 1,583
Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF
Heidorn, S. J., Milagre, C., Whittaker, S., Nourry, A., Niculescu-Duvas, I., Dhomen, N., Hussain, J., Reis-Filho, J. S., Springer, C. J., Pritchard, C., et al. (2010) · Cell · doi:10.1016/j.cell.2009.12.040 · Cited by 1,465
Membrane recognition by phospholipid-binding domains
Lemmon, M. A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2328 · Cited by 1,419
Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity
Tsai, J., Lee, J. T., Wang, W., Zhang, J., Cho, H., Mamo, S., Bremer, R., Gillette, S., Kong, J., Haass, N. K., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711741105 · Cited by 1,346
BRAF mutation predicts sensitivity to MEK inhibition
Solit, D. B., Garraway, L. A., Pratilas, C. A., Sawai, A., Getz, G., Basso, A., Ye, Q., Lobo, J. M., She, Y., Osman, I., et al. (2006) · Nature · doi:10.1038/nature04304 · Cited by 1,328
Raf-1 activates MAP kinase-kinase
Kyriakis, J. M., App, H., Zhang, X.-F., Banerjee, P., Brautigan, D. L., Rapp, U. R., & Avruch, J. (1992) · Nature · doi:10.1038/358417a0 · Cited by 1,283
The extracellular signal-regulated kinase: Multiple substrates regulate diverse cellular functions
Yoon, S., & Seger, R. (2006) · Growth Factors · doi:10.1080/02699050500284218 · Cited by 1,273
The RAF proteins take centre stage
Wellbrock, C., Karasarides, M., & Marais, R. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1498 · Cited by 1,228
RAF/RAS oncogenes and mismatch-repair status
Rajagopalan, H., Bardelli, A., Lengauer, C., Kinzler, K. W., Vogelstein, B., & Velculescu, V. E. (2002) · Nature · doi:10.1038/418934a · Cited by 1,224 · cited 1×
“Interestingly, B-Raf mutations normally do not coexist with oncogenic mutations in Ras in human tumors, arguing that they are equivalent in their transforming effects.(315) This conclusion indeed highlights B-Raf as a critical effector of Ras in cell transformation and cancer.”
BackgroundASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis
Tobiume, K., Matsuzawa, A., Takahashi, T., Nishitoh, H., Morita, K., Takeda, K., Minowa, O., Miyazono, K., Noda, T., & Ichijo, H. (2001) · EMBO reports · doi:10.1093/embo-reports/kve046 · Cited by 1,210
BrafV600E cooperates with Pten loss to induce metastatic melanoma
Dankort, D., Curley, D. P., Cartlidge, R. A., Nelson, B., Karnezis, A. N., Damsky Jr, W. E., You, M. J., DePinho, R. A., McMahon, M., & Bosenberg, M. (2009) · Nature Genetics · doi:10.1038/ng.356 · Cited by 1,189
Ultrasensitivity in the mitogen-activated protein kinase cascade.
Huang, C. Y., & Ferrell, J. E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.19.10078 · Cited by 1,186
Phosphorylation and Regulation of Raf by Akt (Protein Kinase B)
Zimmermann, S., & Moelling, K. (1999) · Science · doi:10.1126/science.286.5445.1741 · Cited by 1,078
Coordinating ERK/MAPK signalling through scaffolds and inhibitors
Kolch, W. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1743 · Cited by 1,070
Self-citationIdentification and validation of oncogenes in liver cancer using an integrative oncogenomic approach
Zender, L., Spector, M. S., Xue, W., Flemming, P., Cordon-Cardo, C., Silke, J., Fan, S.-T., Luk, J. M., Wigler, M., Hannon, G. J., et al. (2006) · Cell · doi:10.1016/j.cell.2006.05.030 · Cited by 1,065
cAMP Activates MAP Kinase and Elk-1 through a B-Raf- and Rap1-Dependent Pathway
Vossler, M. R., Yao, H., York, R. D., Pan, M.-G., Rim, C. S., & Stork, P. J. S. (1997) · Cell · doi:10.1016/s0092-8674(00)80184-1 · Cited by 1,046
Complexes of Ras⋅GTP with Raf-1 and Mitogen-Activated Protein Kinase Kinase
Moodie, S. A., Willumsen, B. M., Weber, M. J., & Wolfman, A. (1993) · Science · doi:10.1126/science.8503013 · Cited by 968
Jones, D. T. W., Kocialkowski, S., Liu, L., Pearson, D. M., Bäcklund, L. M., Ichimura, K., & Collins, V. P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2097 · Cited by 944
A ras-related gene with transformation suppressor activity
Kitayama, H., Sugimoto, Y., Matsuzaki, T., Ikawa, Y., & Noda, M. (1989) · Cell · doi:10.1016/0092-8674(89)90985-9 · Cited by 942
Inhibition by cAMP of Ras-Dependent Activation of Raf
Cook, S. J., & McCormick, F. (1993) · Science · doi:10.1126/science.7694367 · Cited by 922
Inhibition of the EGF-Activated MAP Kinase Signaling Pathway by Adenosine 3′,5′-Monophosphate
Wu, J., Dent, P., Jelinek, T., Wolfman, A., Weber, M. J., & Sturgill, T. W. (1993) · Science · doi:10.1126/science.7694366 · Cited by 919
Defining Network Topologies that Can Achieve Biochemical Adaptation
Ma, W., Trusina, A., El-Samad, H., Lim, W. A., & Tang, C. (2009) · Cell · doi:10.1016/j.cell.2009.06.013 · Cited by 919
Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP
Yeung, K., Seitz, T., Li, S., Janosch, P., McFerran, B., Kaiser, C., Fee, F., Katsanakis, K. D., Rose, D. W., Mischak, H., et al. (1999) · Nature · doi:10.1038/43686 · Cited by 893
Self-citationAn essential role for Rac in Ras transformation
Qiu, R.-G., Chen, J., Kirn, D., McCormick, F., & Symons, M. (1995) · Nature · doi:10.1038/374457a0 · Cited by 882
Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1
Zhang, X.-F., Settleman, J., Kyriakis, J., Takeuchi-Suzuki, E., Elledge, S. J., Marshall, M. S., Bruder, J. T., Rapp, U. R., & Avruch, J. (1993) · Nature · doi:10.1038/364308a0 · Cited by 858
Basu, S., Totty, N. F., Irwin, M. S., Sudol, M., & Downward, J. (2003) · Molecular Cell · doi:10.1016/s1097-2765(02)00776-1 · Cited by 843
DeFea, K. A., Zalevsky, J., Thoma, M. S., Déry, O., Mullins, R. D., & Bunnett, N. W. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.6.1267 · Cited by 822
Bcl-2 Targets the Protein Kinase Raf-1 to Mitochondria
Wang, H.-G., Rapp, U. R., & Reed, J. C. (1996) · Cell · doi:10.1016/s0092-8674(00)81383-5 · Cited by 766
Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro
Warne, P. H., Vician, P. R., & Downward, J. (1993) · Nature · doi:10.1038/364352a0 · Cited by 712
Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy
Pandit, B., Sarkozy, A., Pennacchio, L. A., Carta, C., Oishi, K., Martinelli, S., Pogna, E. A., Schackwitz, W., Ustaszewska, A., Landstrom, A., et al. (2007) · Nature Genetics · doi:10.1038/ng2073 · Cited by 698
Signaling switches and bistability arising from multisite phosphorylation in protein kinase cascades
Markevich, N. I., Hoek, J. B., & Kholodenko, B. N. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200308060 · Cited by 692
Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation
Khosravi-Far, R., Solski, P. A., Clark, G. J., Kinch, M. S., & Der, C. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.11.6443 · Cited by 683
Activation of Mitogen-Activated Protein Kinase Kinase by v-Raf in NIH 3T3 Cells and in Vitro
Dent, P., Haser, W., Haystead, T. A. J., Vincent, L. A., Roberts, T. M., & Sturgill, T. W. (1992) · Science · doi:10.1126/science.1326789 · Cited by 668
Determinants of BRAF Mutations in Primary Melanomas
Maldonado, J. L., Fridlyand, J., Patel, H., Jain, A. N., Busam, K., Kageshita, T., Ono, T., Albertson, D. G., Pinkel, D., & Bastian, B. C. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg123 · Cited by 664 · cited 1×
“frequent event in melanoma, suggesting that B-Raf mutations are one of the factors driving its selection.(329) Elevated levels of A-Raf mRNA and protein were observed in a number of malignancies including head and neck squamous cell carcinomas and colon carcinomas.”
BackgroundRinehart, J., Adjei, A. A., LoRusso, P. M., Waterhouse, D., Hecht, J. R., Natale, R. B., Hamid, O., Varterasian, M., Asbury, P., Kaldjian, E. P., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.01.185 · Cited by 645
Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis
Eisen, T., Ahmad, T., Flaherty, K. T., Gore, M., Kaye, S., Marais, R., Gibbens, I., Hackett, S., James, M., Schuchter, L. M., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603291 · Cited by 644
Nassar, N., Horn, G., Herrmann, C. A., Scherer, A., McCormick, F., & Wittinghofer, A. (1995) · Nature · doi:10.1038/375554a0 · Cited by 635
Regulation of Raf-1 by Direct Feedback Phosphorylation
Dougherty, M. K., Müller, J., Ritt, D. A., Zhou, M., Zhou, X. Z., Copeland, T. D., Conrads, T. P., Veenstra, T. D., Lu, K. P., & Morrison, D. K. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.11.055 · Cited by 633
Complex formation between RAS and RAF and other protein kinases.
Van Aelst, L., Barr, M., Marcus, S., Polverino, A., & Wigler, M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.13.6213 · Cited by 622
Integrating signals from RTKs to ERK/MAPK
McKay, M. M., & Morrison, D. K. (2007) · Oncogene · doi:10.1038/sj.onc.1210394 · Cited by 621
Signalling ballet in space and time
Kholodenko, B. N., Hancock, J. F., & Kolch, W. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2901 · Cited by 614
Self-citationRas recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation.
Marais, R., Light, Y., Paterson, H. F., & Marshall, C. J. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07316.x · Cited by 612
Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate
Santos, S. D. M., Verveer, P. J., & Bastiaens, P. I. H. (2007) · Nature Cell Biology · doi:10.1038/ncb1543 · Cited by 609
Brown, M. C., & Turner, C. E. (2004) · Physiological Reviews · doi:10.1152/physrev.00002.2004 · Cited by 609
Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome
Niihori, T., Aoki, Y., Narumi, Y., Neri, G., Cavé, H., Verloes, A., Okamoto, N., Hennekam, R. C. M., Gillessen-Kaesbach, G., Wieczorek, D., et al. (2006) · Nature Genetics · doi:10.1038/ng1749 · Cited by 599
Ras signalling on the endoplasmic reticulum and the Golgi
Chiu, V. K., Bivona, T., Hach, A., Sajous, J. B., Silletti, J., Wiener, H., Johnson, R. L., Cox, A. D., & Philips, M. R. (2002) · Nature Cell Biology · doi:10.1038/ncb783 · Cited by 594 · cited 1×
“reticulum.(60,63,64) The subcellular localization modulates the efficiency with which different effector pathways are engaged but, in the case of Raf-1, also has a major influence on the dynamics of signaling.”
BackgroundOncogenic Braf Induces Melanocyte Senescence and Melanoma in Mice
Dhomen, N., Reis-Filho, J. S., da Rocha Dias, S., Hayward, R., Savage, K., Delmas, V., Larue, L., Pritchard, C., & Marais, R. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.02.022 · Cited by 594
Thymic selection threshold defined by compartmentalization of Ras/MAPK signalling
Daniels, M. A., Teixeiro, E., Gill, J., Hausmann, B., Roubaty, D., Holmberg, K., Werlen, G., Holländer, G. A., Gascoigne, N. R. J., & Palmer, E. (2006) · Nature · doi:10.1038/nature05269 · Cited by 577
Germline Mutations in Genes Within the MAPK Pathway Cause Cardio-facio-cutaneous Syndrome
Rodriguez-Viciana, P., Tetsu, O., Tidyman, W. E., Estep, A. L., Conger, B. A., Cruz, M. S., McCormick, F., & Rauen, K. A. (2006) · Science · doi:10.1126/science.1124642 · Cited by 571
Emerging roles of pseudokinases
Boudeau, J., Miranda-Saavedra, D., Barton, G. J., & Alessi, D. R. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.07.003 · Cited by 547
GTP-dependent segregation of H-ras from lipid rafts is required for biological activity
Prior, I. A., Harding, A., Yan, J., Sluimer, J., Parton, R. G., & Hancock, J. F. (2001) · Nature Cell Biology · doi:10.1038/35070050 · Cited by 518
Deakin, N. O., & Turner, C. E. (2008) · Journal of Cell Science · doi:10.1242/jcs.018044 · Cited by 498
Germline gain-of-function mutations in RAF1 cause Noonan syndrome
Razzaque, M. A., Nishizawa, T., Komoike, Y., Yagi, H., Furutani, M., Amo, R., Kamisago, M., Momma, K., Katayama, H., Nakagawa, M., et al. (2007) · Nature Genetics · doi:10.1038/ng2078 · Cited by 498
A dimerization-dependent mechanism drives RAF catalytic activation
Rajakulendran, T., Sahmi, M., Lefrançois, M., Sicheri, F., & Therrien, M. (2009) · Nature · doi:10.1038/nature08314 · Cited by 489
Levchenko, A., Bruck, J., & Sternberg, P. W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.11.5818 · Cited by 486
Structure and biological activity of v-raf, a unique oncogene transduced by a retrovirus.
Rapp, U. R., Goldsborough, M. D., Mark, G. E., Bonner, T. I., Groffen, J., Reynolds, F. H., & Stephenson, J. R. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.14.4218 · Cited by 483
Margarit, S. M., Sondermann, H., Hall, B. E., Nagar, B., Hoelz, A., Pirruccello, M., Bar-Sagi, D., & Kuriyan, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00149-1 · Cited by 480
A dimeric 14-3-3 protein is an essential cofactor for Raf kinase activity
Tzivion, G., Luo, Z., & Avruch, J. (1998) · Nature · doi:10.1038/27938 · Cited by 476
Raf-1 protein kinase is required for growth of induced NIH/3T3 cells
Kolch, W., Heidecker, G., Lloyd, P., & Rapp, U. R. (1991) · Nature · doi:10.1038/349426a0 · Cited by 474
Self-citationMP1: A MEK Binding Partner That Enhances Enzymatic Activation of the MAP Kinase Cascade
Schaeffer, H. J., Catling, A. D., Eblen, S. T., Collier, L. S., Krauss, A., & Weber, M. J. (1998) · Science · doi:10.1126/science.281.5383.1668 · Cited by 471
Targeting the RAF–MEK–ERK pathway in cancer therapy
Montagut, C., & Settleman, J. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.01.022 · Cited by 468
Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma
Palanisamy, N., Ateeq, B., Kalyana-Sundaram, S., Pflueger, D., Ramnarayanan, K., Shankar, S., Han, B., Cao, Q., Cao, X., Suleman, K., et al. (2010) · Nature Medicine · doi:10.1038/nm.2166 · Cited by 464
Myc pathways provoking cell suicide and cancer
Nilsson, J. A., & Cleveland, J. L. (2003) · Oncogene · doi:10.1038/sj.onc.1207261 · Cited by 462
Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer
Ciampi, R., Knauf, J. A., Kerler, R., Gandhi, M., Zhu, Z., Nikiforova, M. N., Rabes, H. M., Fagin, J. A., & Nikiforov, Y. E. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523237 · Cited by 461
Serine and tyrosine phosphorylations cooperate in Raf-1, but not B-Raf activation
Mason, C. S. (1999) · The EMBO Journal · doi:10.1093/emboj/18.8.2137 · Cited by 457
Differential Regulation of Raf-1, A-Raf, and B-Raf by Oncogenic Ras and Tyrosine Kinases
Marais, R., Light, Y., Paterson, H. F., Mason, C. S., & Marshall, C. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.7.4378 · Cited by 456
Spred is a Sprouty-related suppressor of Ras signalling
Wakioka, T., Sasaki, A., Kato, R., Shouda, T., Matsumoto, A., Miyoshi, K., Tsuneoka, M., Komiya, S., Baron, R., & Yoshimura, A. (2001) · Nature · doi:10.1038/35088082 · Cited by 445
The protein kinase Pak3 positively regulates Raf-1 activity through phosphorylation of serine 338
King, A. J., Sun, H., Diaz, B., Barnard, D., Miao, W., Bagrodia, S., & Marshall, M. S. (1998) · Nature · doi:10.1038/24184 · Cited by 443
Sprouty proteins: multifaceted negative-feedback regulators of receptor tyrosine kinase signaling
Mason, J. M., Morrison, D. J., Albert Basson, M., & Licht, J. D. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.11.004 · Cited by 424
The Incoherent Feedforward Loop Can Provide Fold-Change Detection in Gene Regulation
Goentoro, L., Shoval, O., Kirschner, M. W., & Alon, U. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.11.018 · Cited by 424
Reduced MAP Kinase Phosphatase-1 Degradation After p42/p44 MAPK -Dependent Phosphorylation
Brondello, J.-M., Pouysségur, J., & McKenzie, F. R. (1999) · Science · doi:10.1126/science.286.5449.2514 · Cited by 419
Regulation and Role of Raf-1/B-Raf Heterodimerization
Rushworth, L. K., Hindley, A. D., O'Neill, E., & Kolch, W. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.6.2262-2272.2006 · Cited by 418
Self-citationMatallanas, D., Romano, D., Yee, K., Meissl, K., Kucerova, L., Piazzolla, D., Baccarini, M., Vass, J. K., Kolch, W., & O'Neill, E. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.08.008 · Cited by 416
Self-citationWild-Type and Mutant B-RAF Activate C-RAF through Distinct Mechanisms Involving Heterodimerization
Garnett, M. J., Rana, S., Paterson, H., Barford, D., & Marais, R. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.10.022 · Cited by 416
Cross-cascade activation of ERKs and ternary complex factors by Rho family proteins
Frost, J. A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.21.6426 · Cited by 414
Plasma membrane nanoswitches generate high-fidelity Ras signal transduction
Tian, T., Harding, A., Inder, K., Plowman, S., Parton, R. G., & Hancock, J. F. (2007) · Nature Cell Biology · doi:10.1038/ncb1615 · Cited by 407
LoRusso, P. M., Adjei, A. A., Varterasian, M., Gadgeel, S., Reid, J., Mitchell, D. Y., Hanson, L., DeLuca, P., Bruzek, L., Piens, J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.14.415 · Cited by 401
Autocrine, paracrine and juxtacrine signaling by EGFR ligands
Singh, A. B., & Harris, R. C. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.03.026 · Cited by 400
Digital signaling and hysteresis characterize Ras activation in lymphoid cells.
Das, J., Ho, M., Zikherman, J., Govern, C., Yang, M., Weiss, A., Chakraborty, A. K., & Roose, J. P. (2009) · Cell · doi:10.1016/j.cell.2008.11.051 · Cited by 398 · cited 3×
“In T lymphocytes, this positive feedback is key to establish a bistable Ras response that contributes to the establishment of memory cells, which maintain the ability to be rapidly reactivated by the specific antigens they have encountered before.(410) The biological relevance of positive feedback includes the generat…”
BackgroundRegulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway (Review).
Chang, F., Steelman, L. S., Shelton, J. G., Lee, J. T., Navolanic, P. M., Blalock, W. L., Franklin, R. A., & McCubrey, J. A. (2003) · PubMed · Cited by 392
Chen, W. W., Schoeberl, B., Jasper, P. J., Niepel, M., Nielsen, U. B., Lauffenburger, D. A., & Sorger, P. K. (2009) · Molecular Systems Biology · doi:10.1038/msb.2008.74 · Cited by 391
Yeung, K., Janosch, P., McFerran, B., Rose, D. W., Mischak, H., Sedivy, J. M., & Kolch, W. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.9.3079-3085.2000 · Cited by 389
Self-citationRegulation of Raf-Akt Cross-talk
Moelling, K., Schad, K., Bosse, M., Zimmermann, S., & Schweneker, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111974200 · Cited by 387
Teis, D., Wunderlich, W., & Huber, L. A. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00364-7 · Cited by 371
The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders
Aoki, Y., Niihori, T., Narumi, Y., Kure, S., & Matsubara, Y. (2008) · Human Mutation · doi:10.1002/humu.20748 · Cited by 365
Effects of Raf Kinase Inhibitor Protein Expression on Suppression of Prostate Cancer Metastasis
Fu, Z., Smith, P. C., Zhang, L., Rubin, M. A., Dunn, R. L., Yao, Z., & Keller, E. T. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.12.878 · Cited by 364
Brondello, J.-M., Brunet, A., Pouysségur, J., & McKenzie, F. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.2.1368 · Cited by 361
Strano, S., Monti, O., Pediconi, N., Baccarini, A., Fontemaggi, G., Lapi, E., Mantovani, F., Damalas, A., Citro, G., Sacchi, A., et al. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.04.008 · Cited by 360
Corbit, K. C., Trakul, N., Eves, E. M., Diaz, B., Marshall, M., & Rosner, M. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210015200 · Cited by 360
Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface
Zhang, X., Pickin, K. A., Bose, R., Jura, N., Cole, P. A., & Kuriyan, J. (2007) · Nature · doi:10.1038/nature05998 · Cited by 357
Computational modelling of the receptor-tyrosine-kinase-activated MAPK pathway
Orton, R. J., Sturm, O. E., Vyshemirsky, V., Calder, M., Gilbert, D. R., & Kolch, W. (2005) · Biochemical Journal · doi:10.1042/bj20050908 · Cited by 355
Self-citationCritical tyrosine residues regulate the enzymatic and biological activity of Raf-1 kinase.
Fabian, J. R., Daar, I. O., & Morrison, D. K. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.11.7170 · Cited by 353
RapV12 antagonizes Ras-dependent activation of ERK1 and ERK2 by LPA and EGF in Rat-1 fibroblasts.
Cook, S. J., Rubinfeld, B., Albert, I., & McCormick, F. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06022.x · Cited by 349
Mechanistic Studies of the Dual Phosphorylation of Mitogen-activated Protein Kinase
Ferrell, J. E., & Bhatt, R. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.30.19008 · Cited by 344
PRASKOVA, M., KHOKLATCHEV, A., ORTIZ-VEGA, S., & AVRUCH, J. (2004) · Biochemical Journal · doi:10.1042/bj20040025 · Cited by 342
Nada, S., Hondo, A., Kasai, A., Koike, M., Saito, K., Uchiyama, Y., & Okada, M. (2009) · The EMBO Journal · doi:10.1038/emboj.2008.308 · Cited by 341
Dynamics of the Ras/ERK MAPK Cascade as Monitored by Fluorescent Probes
Fujioka, A., Terai, K., Itoh, R. E., Aoki, K., Nakamura, T., Kuroda, S., Nishida, E., & Matsuda, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509344200 · Cited by 340
KSR, a novel protein kinase required for RAS signal transduction
Therrien, M., Chang, H. C., Solomon, N. M., Karim, F. D., Wassarman, D. A., & Rubin, G. M. (1995) · Cell · doi:10.1016/0092-8674(95)90204-x · Cited by 339
Hagel, M., George, E. L., Kim, A., Tamimi, R., Opitz, S. L., Turner, C. E., Imamoto, A., & Thomas, S. M. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.3.901-915.2002 · Cited by 332
IQGAP proteins are integral components of cytoskeletal regulation
Briggs, M. W., & Sacks, D. B. (2003) · EMBO reports · doi:10.1038/sj.embor.embor867 · Cited by 330
Identification of the major phosphorylation sites of the Raf-1 kinase
Morrison, D. K., Heidecker, G., Rapp, U. R., & Copeland, T. D. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85336-x · Cited by 328
Rodriguez-Viciana, P., Sabatier, C., & McCormick, F. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.11.4943-4954.2004 · Cited by 327 · cited 15×
“Chemical inhibition of Rok-α or expression of a dominant-negative Rok-α mutant rescues all these defects of the Raf-1–deficient cells, indicating that Rok-α is the only target of Raf-1 in motility.19 Interestingly, investigating the mechanism of Rho-α inhibition by Raf-1 revealed a critical role for the Raf-1 CRD. Rok…”
BackgroundInfluentialJones, D. T. W., Kocialkowski, S., Liu, L., Pearson, D. M., Ichimura, K., & Collins, V. P. (2009) · Oncogene · doi:10.1038/onc.2009.73 · Cited by 321
Mutant V599EB-Raf Regulates Growth and Vascular Development of Malignant Melanoma Tumors
Sharma, A., Trivedi, N. R., Zimmerman, M. A., Tuveson, D. A., Smith, C. D., & Robertson, G. P. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2423 · Cited by 321
Activation of the Raf-1 kinase cascade by coumermycin-induced dimerization
Farrar, M. A., Alberola-lla, J., & Perlmutter, R. M. (1996) · Nature · doi:10.1038/383178a0 · Cited by 318
Role of the Kinase MST2 in Suppression of Apoptosis by the Proto-Oncogene Product Raf-1
O'Neill, E., Rushworth, L., Baccarini, M., & Kolch, W. (2004) · Science · doi:10.1126/science.1103233 · Cited by 317
Self-citationRaf kinases: Function, regulation and role in human cancer
Leicht, D. T., Balan, V., Kaplun, A., Singh-Gupta, V., Kaplun, L., Dobson, M., & Tzivion, G. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.05.001 · Cited by 317
Chen, J., Fujii, K., Zhang, L., Roberts, T., & Fu, H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.141224398 · Cited by 316
PEA-15 Mediates Cytoplasmic Sequestration of ERK MAP Kinase
Formstecher, E., Ramos, J. W., Fauquet, M., Calderwood, D. A., Hsieh, J.-C., Canton, B., Nguyen, X.-T., Barnier, J.-V., Camonis, J., Ginsberg, M. H., et al. (2001) · Developmental Cell · doi:10.1016/s1534-5807(01)00035-1 · Cited by 313
Active Ras induces heterodimerization of cRaf and BRaf.
Weber, C., Slupsky, J. R., Kalmes, H. A., & Rapp, U. R. (2001) · PubMed · Cited by 312
Mechanism of inhibition of Raf-1 by protein kinase A
Häfner, S., Adler, H. S., Mischak, H., Janosch, P., Heidecker, G., Wolfman, A., Pippig, S., Lohse, M., Ueffing, M., & Kolch, W. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.10.6696 · Cited by 312
Self-citationEmbryonic lethality and fetal liver apoptosis in mice lacking the c-raf-1 gene
Mikula, M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.8.1952 · Cited by 311
MEK kinase activity is not necessary for Raf-1 function
Huser, M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.8.1940 · Cited by 310
Efficient and targeted delivery of siRNA in vivo
Shim, M. S., & Kwon, Y. J. (2010) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07904.x · Cited by 309
Sundaram, M., & Han, M. (1995) · Cell · doi:10.1016/0092-8674(95)90205-8 · Cited by 306
IQGAPs in cancer: A family of scaffold proteins underlying tumorigenesis
White, C. D., Brown, M. D., & Sacks, D. B. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.05.007 · Cited by 306
Sarkozy, A., Carta, C., Moretti, S., Zampino, G., Digilio, M. C., Pantaleoni, F., Scioletti, A. P., Esposito, G., Cordeddu, V., Lepri, F., et al. (2009) · Human Mutation · doi:10.1002/humu.20955 · Cited by 303 · cited 1×
“Compared to the V600E mutation, the kinase activity and transforming capacity of CFC B-Raf mutants seem to be lower.(333,337) Germline mutations in Raf-1 were recently described in both Noonan and LEOPARD syndromes.”
BackgroundThe ksr-1 gene encodes a novel protein kinase involved in Ras-mediated signaling in C. elegans
Kornfeld, K., Hom, D. B., & Horvitz, H. R. (1995) · Cell · doi:10.1016/0092-8674(95)90206-6 · Cited by 299
Ory, S., Zhou, M., Conrads, T. P., Veenstra, T. D., & Morrison, D. K. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00535-9 · Cited by 296
The RASSF proteins in cancer; from epigenetic silencing to functional characterization
Richter, A. M., Pfeifer, G. P., & Dammann, R. H. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.03.004 · Cited by 295
Phospholipase D2-generated phosphatidic acid couples EGFR stimulation to Ras activation by Sos
Zhao, C., Du, G., Skowronek, K., Frohman, M. A., & Bar-Sagi, D. (2007) · Nature Cell Biology · doi:10.1038/ncb1594 · Cited by 293
Nijtmans, L. G. J., Artal Sanz, M., Grivell, L. A., & Coates, P. J. (2002) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-002-8411-0 · Cited by 292
Cell fate decisions are specified by the dynamic ERK interactome
von Kriegsheim, A., Baiocchi, D., Birtwistle, M., Sumpton, D., Bienvenut, W., Morrice, N., Yamada, K., Lamond, A., Kalna, G., Orton, R., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1994 · Cited by 286
Self-citationNegative Regulation of the Serine/Threonine Kinase B-Raf by Akt
Guan, K.-L., Figueroa, C., Brtva, T. R., Zhu, T., Taylor, J., Barber, T. D., & Vojtek, A. B. (2000) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)61518-8 · Cited by 281
Regulation of Raf-1 activation and signalling by dephosphorylation
Dhillon, A. S. (2002) · The EMBO Journal · doi:10.1093/emboj/21.1.64 · Cited by 280
Sef Is a Spatial Regulator for Ras/MAP Kinase Signaling
Torii, S., Kusakabe, M., Yamamoto, T., Maekawa, M., & Nishida, E. (2004) · Developmental Cell · doi:10.1016/j.devcel.2004.05.019 · Cited by 278
Nguyen, A., Burack, W. R., Stock, J. L., Kortum, R., Chaika, O. V., Afkarian, M., Muller, W. J., Murphy, K. M., Morrison, D. K., Lewis, R. E., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.9.3035-3045.2002 · Cited by 268
Gan, Y., Shi, C., Inge, L., Hibner, M., Balducci, J., & Huang, Y. (2010) · Oncogene · doi:10.1038/onc.2010.240 · Cited by 266
Paradoxical activation of Raf by a novel Raf inhibitor
Hall-Jackson, C. A., Eyers, P. A., Cohen, P., Goedert, M., Tom Boyle, F., Hewitt, N., Plant, H., & Hedge, P. (1999) · Chemistry & Biology · doi:10.1016/s1074-5521(99)80088-x · Cited by 265
KSR modulates signal propagation within the MAPK cascade.
Therrien, M., Michaud, N. R., Rubin, G. M., & Morrison, D. K. (1996) · Genes & Development · doi:10.1101/gad.10.21.2684 · Cited by 257
Positive and negative regulation of Raf kinase activity and function by phosphorylation
Chong, H. (2001) · The EMBO Journal · doi:10.1093/emboj/20.14.3716 · Cited by 255
Dumaz, N., & Marais, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300182200 · Cited by 252
BAD: undertaker by night, candyman by day
Danial, N. N. (2008) · Oncogene · doi:10.1038/onc.2009.44 · Cited by 252
Reduction of Raf-1 Kinase Inhibitor Protein Expression Correlates with Breast Cancer Metastasis
Hagan, S., Al-Mulla, F., Mallon, E., Oien, K., Ferrier, R., Gusterson, B., Curto García, J. J., & Kolch, W. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0283 · Cited by 252
Self-citationMammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1
Sasaki, A., Taketomi, T., Kato, R., Saeki, K., Nonami, A., Sasaki, M., Kuriyama, M., Saito, N., Shibuya, M., & Yoshimura, A. (2003) · Nature Cell Biology · doi:10.1038/ncb978 · Cited by 251
IQGAP1 Is a Scaffold for Mitogen-Activated Protein Kinase Signaling
Roy, M., Li, Z., & Sacks, D. B. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.18.7940-7952.2005 · Cited by 248
The Mammalian MAPK/ERK Pathway Exhibits Properties of a Negative Feedback Amplifier
Sturm, O. E., Orton, R., Grindlay, J., Birtwistle, M., Vyshemirsky, V., Gilbert, D., Calder, M., Pitt, A., Kholodenko, B., & Kolch, W. (2010) · Science Signaling · doi:10.1126/scisignal.2001212 · Cited by 247
Self-citationActivation of B-Raf kinase requires phosphorylation of the conserved residues Thr598 and Ser601
Zhang, B.-H. (2000) · The EMBO Journal · doi:10.1093/emboj/19.20.5429 · Cited by 245
From basic research to clinical development of MEK1/2 inhibitors for cancer therapy
Frémin, C., & Meloche, S. (2010) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-3-8 · Cited by 243
Ligand-Specific c-Fos Expression Emerges from the Spatiotemporal Control of ErbB Network Dynamics
Nakakuki, T., Birtwistle, M. R., Saeki, Y., Yumoto, N., Ide, K., Nagashima, T., Brusch, L., Ogunnaike, B. A., Okada-Hatakeyama, M., & Kholodenko, B. N. (2010) · Cell · doi:10.1016/j.cell.2010.03.054 · Cited by 241
Self-citationSerine- and threonine-specific protein kinase activities of purified gag–mil and gag–raf proteins
Moelling, K., Heimann, B., Beimling, P., Rapp, U. R., & Sander, T. (1984) · Nature · doi:10.1038/312558a0 · Cited by 240
Mutational activation of c-raf-1 and definition of the minimal transforming sequence.
Heidecker, G., Huleihel, M., Cleveland, J. L., Kolch, W., Beck, T. W., Lloyd, P., Pawson, T., & Rapp, U. R. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.6.2503 · Cited by 240
Self-citationImpact of Feedback Phosphorylation and Raf Heterodimerization on Normal and Mutant B-Raf Signaling
Ritt, D. A., Monson, D. M., Specht, S. I., & Morrison, D. K. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00569-09 · Cited by 238
Oligomerization activates c-Raf-1 through a Ras-dependent mechanism
Luo, Z., Tzivion, G., Belshaw, P. J., Vavvas, D., Marshall, M., & Avruch, J. (1996) · Nature · doi:10.1038/383181a0 · Cited by 237
Rapid and sustained nuclear–cytoplasmic ERK oscillations induced by epidermal growth factor
Shankaran, H., Ippolito, D. L., Chrisler, W. B., Resat, H., Bollinger, N., Opresko, L. K., & Wiley, H. S. (2009) · Molecular Systems Biology · doi:10.1038/msb.2009.90 · Cited by 235
KSR: a MAPK scaffold of the Ras pathway?
Morrison, D. K. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.9.1609 · Cited by 233
Adams, J. A. (2003) · Biochemistry · doi:10.1021/bi020617o · Cited by 233
Cyclic AMP-Dependent Kinase Regulates Raf-1 Kinase Mainly by Phosphorylation of Serine 259
Dhillon, A. S., Pollock, C., Steen, H., Shaw, P. E., Mischak, H., & Kolch, W. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.10.3237-3246.2002 · Cited by 230
Self-citationSprouty proteins, masterminds of receptor tyrosine kinase signaling
Cabrita, M. A., & Christofori, G. (2008) · Angiogenesis · doi:10.1007/s10456-008-9089-1 · Cited by 229
Søndergaard, J. N., Nazarian, R., Wang, Q., Guo, D., Hsueh, T., Mok, S., Sazegar, H., MacConaill, L. E., Barretina, J. G., Kehoe, S. M., et al. (2010) · Journal of Translational Medicine · doi:10.1186/1479-5876-8-39 · Cited by 228
Targeting the MAPK pathway in melanoma: Why some approaches succeed and other fail
Inamdar, G. S., Madhunapantula, S. V., & Robertson, G. P. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.04.029 · Cited by 225
Phosphatidylinositol 3-kinase regulates Raf1 through Pak phosphorylation of serine 338
Chaudhary, A., King, W. G., Mattaliano, M. D., Frost, J. A., Diaz, B., Morrison, D. K., Cobb, M. H., Marshall, M. S., & Brugge, J. S. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00475-9 · Cited by 225
Protein scaffolds in MAP kinase signalling
Brown, M. D., & Sacks, D. B. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2008.11.013 · Cited by 224
Eblen, S. T., Slack, J. K., Weber, M. J., & Catling, A. D. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.17.6023-6033.2002 · Cited by 222
14-3-3 Proteins Are Required for Maintenance of Raf-1 Phosphorylation and Kinase Activity
Thorson, J. A., Yu, L. W. K., Hsu, A. L., Shih, N.-Y., Graves, P. R., Tanner, J. W., Allen, P. M., Piwnica-Worms, H., & Shaw, A. S. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.9.5229 · Cited by 220
The engine driving the ship: metabolic steering of cell proliferation and death
Buchakjian, M. R., & Kornbluth, S. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2972 · Cited by 219
Ishibe, S., Joly, D., Zhu, X., & Cantley, L. G. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00406-4 · Cited by 218
IQGAP1 Binds Rap1 and Modulates Its Activity
Jeong, H.-W., Li, Z., Brown, M. D., & Sacks, D. B. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700487200 · Cited by 218
Quantitative analysis of signaling networks
Sauro, H. M., & Kholodenko, B. N. (2004) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2004.03.002 · Cited by 217
The role of Rap1 in integrin-mediated cell adhesion
Bos, J. L., de Bruyn, K., Enserink, J., Kuiperij, B., Rangarajan, S., Rehmann, H., Riedl, J., de Rooij, J., van Mansfeld, F., & Zwartkruis, F. (2003) · Biochemical Society Transactions · doi:10.1042/bst0310083 · Cited by 216
Rodriguez-Viciana, P., Oses-Prieto, J., Burlingame, A., Fried, M., & McCormick, F. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.027 · Cited by 215
Negative Regulation of Raf-1 by Phosphorylation of Serine 621
Mischak, H., Seitz, T., Janosch, P., Eulitz, M., Steen, H., Schellerer, M., Philipp, A., & Kolch, W. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.10.5409 · Cited by 213
Self-citationTeis, D., Taub, N., Kurzbauer, R., Hilber, D., de Araujo, M. E., Erlacher, M., Offterdinger, M., Villunger, A., Geley, S., Bohn, G., et al. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200607025 · Cited by 210
Bistability and Oscillations in the Huang-Ferrell Model of MAPK Signaling
Qiao, L., Nachbar, R. B., Kevrekidis, I. G., & Shvartsman, S. Y. (2007) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0030184 · Cited by 210
Northwood, I. C., Gonzalez, F. A., Wartmann, M., Raden, D. L., & Davis, R. J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98612-6 · Cited by 209
Emuss, V., Garnett, M., Mason, C., The Cancer Genome Project, & Marais, R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1683 · Cited by 207
Raf-1 regulates Rho signaling and cell migration
Ehrenreiter, K., Piazzolla, D., Velamoor, V., Sobczak, I., Small, J. V., Takeda, J., Leung, T., & Baccarini, M. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200409162 · Cited by 207
IQGAP1 Binds ERK2 and Modulates Its Activity
Roy, M., Li, Z., & Sacks, D. B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308405200 · Cited by 205
A Novel Role for Gab1 and SHP2 in Epidermal Growth Factor-induced Ras Activation
Montagner, A., Yart, A., Dance, M., Perret, B., Salles, J.-P., & Raynal, P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410012200 · Cited by 204
Cardiac-specific disruption of the c-raf-1 gene induces cardiac dysfunction and apoptosis
Yamaguchi, O., Watanabe, T., Nishida, K., Kashiwase, K., Higuchi, Y., Takeda, T., Hikoso, S., Hirotani, S., Asahi, M., Taniike, M., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420317 · Cited by 204
Diaz, B., Barnard, D., Filson, A., MacDonald, S., King, A., & Marshall, M. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.8.4509 · Cited by 203
Houslay, M. D., & Kolch, W. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23096-0 · Cited by 202
Self-citationFunctional proteomics to dissect tyrosine kinase signalling pathways in cancer
Kolch, W., & Pitt, A. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2900 · Cited by 200
Self-citationThe solution structure of the Raf-1 cysteine-rich domain: a novel ras and phospholipid binding site.
Mott, H. R., Carpenter, J. W., Zhong, S., Ghosh, S., Bell, R. M., & Campbell, S. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8312 · Cited by 199
Autoregulation of the Raf-1 serine/threonine kinase
Cutler, R. E., Stephens, R. M., Saracino, M. R., & Morrison, D. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9214 · Cited by 198
Protein phosphatases 1 and 2A promote Raf-1 activation by regulating 14-3-3 interactions
Jaumot, M., & Hancock, J. F. (2001) · Oncogene · doi:10.1038/sj.onc.1204526 · Cited by 196
Kiyatkin, A., Aksamitiene, E., Markevich, N. I., Borisov, N. M., Hoek, J. B., & Kholodenko, B. N. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600482200 · Cited by 195
BRAF Signaling and Targeted Therapies in Melanoma
Dhomen, N., & Marais, R. (2009) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2009.04.001 · Cited by 195
Structure and biological activity of human homologs of the raf/mil oncogene.
Bonner, T. I., Kerby, S. B., Sutrave, P., Gunnell, M. A., Mark, G., & Rapp, U. R. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.6.1400 · Cited by 193
Shin, S.-Y., Rath, O., Choo, S.-M., Fee, F., McFerran, B., Kolch, W., & Cho, K.-H. (2009) · Journal of Cell Science · doi:10.1242/jcs.036319 · Cited by 192
Self-citationLee, H. C., Tian, B., Sedivy, J. M., Wands, J. R., & Kim, M. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.07.012 · Cited by 190
SOS Phosphorylation and Disassociation of the Grb2-SOS Complex by the ERK and JNK Signaling Pathways
Chen§, D., Waters§, S. B., Holt, K. H., & Pessin, J. E. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.11.6328 · Cited by 183
A Mek1–Mek2 heterodimer determines the strength and duration of the Erk signal
Catalanotti, F., Reyes, G., Jesenberger, V., Galabova-Kovacs, G., de Matos Simoes, R., Carugo, O., & Baccarini, M. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1564 · Cited by 182
Cited by
Targeting RAS–ERK signalling in cancer: promises and challenges
Samatar, A. A., & Poulikakos, P. I. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4281 · Cited by 1,163
A Comprehensive Review on MAPK: A Promising Therapeutic Target in Cancer
Braicu, C., Buse, M., Busuioc, C., Drula, R., Gulei, D., Raduly, L., Rusu, A., Irimie, A., Atanasov, A. G., Slaby, O., et al. (2019) · Cancers · doi:10.3390/cancers11101618 · Cited by 944
Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies
Bahar, M. E., Kim, H. J., & Kim, D. R. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01705-z · Cited by 888
Targeting MAPK Signaling in Cancer: Mechanisms of Drug Resistance and Sensitivity
Lee, S., Rauch, J., & Kolch, W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031102 · Cited by 799
Self-citationRegulation of RAF protein kinases in ERK signalling
Lavoie, H., & Therrien, M. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3979 · Cited by 702
Metadata
- Authors
- Matallanas, D., Birtwistle, M., Romano, D., Zebisch, A., Rauch, J., von Kriegsheim, A., & Kolch, W.
- Venue
- Genes & Cancer
- Publisher
- SAGE Publications
- Published
- 2011-03-01
- Volume
- 2
- Issue
- 3
- Pages
- 232-260
- ISSN
- 1947-6019 (ISSN-L)
- 1947-6027
- OpenAlex
- W2000581759
- Cited by
- 386
- References
- 409
- FWCI
- 8.82
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.